AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sobottka, I.
Right arrow Articles by Mack, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sobottka, I.
Right arrow Articles by Mack, D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2002, p. 4019-4021, Vol. 46, No. 12
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.12.4019-4021.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

In Vitro Activity of Moxifloxacin against Bacteria Isolated from Odontogenic Abscesses

Ingo Sobottka,1* Georg Cachovan,2 Enno Stürenburg,1 M. Oliver Ahlers,2 Rainer Laufs,1 Ursula Platzer,2 and Dietrich Mack1

Institute of Medical Microbiology and Immunology,1 Department of Operative Dentistry and Periodontology, School of Dentistry, University Hospital Eppendorf, Hamburg, Germany2

Received 23 January 2002/ Returned for modification 24 June 2002/ Accepted 11 September 2002

We evaluated the antimicrobial susceptibility of 87 pathogens isolated from 37 patients with odontogenic abscesses. The most prevalent bacteria were viridans group streptococci and Prevotella species. Considering all bacterial isolates, 100% were susceptible to amoxicillin-clavulanic acid, 98% were susceptible to moxifloxacin and to levofloxacin, 76% were susceptible to doxycycline, 75% were susceptible to clindamycin, and 69% were susceptible to penicillin.


* Corresponding author. Mailing address: Institute of Medical Microbiology and Immunology, University Hospital Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany. Phone: 49-40-42803-3157. Fax: 49-40-42803-4881. E-mail: sobottka{at}uke.uni-hamburg.de.


Antimicrobial Agents and Chemotherapy, December 2002, p. 4019-4021, Vol. 46, No. 12
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.12.4019-4021.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.